Skip to main content
Premium Trial:

Request an Annual Quote

Amaxa, Fisher's Dharmacon Pen siRNA Cell-Delivery Alliance

NEW YORK, June 6 (GenomeWeb News) - Fisher Biosciences' Dharmacon unit and German biotech Amaxa will "co-promote" data generated using Dharmacon's siRNA libraries with Amaxa's Nucleofector technology, the companies said today.
Dharmacon will work with Amaxa to provide combined customers with "technical service, pre-tested protocols, and application models to optimize the use of [Dharmacon's] siRNA reagents with the Amaxa technology," William Marshall, vice president of technology and business development for Fisher Biosciences, said in a statement.
Amaxa's Nucleofector 96-well Shuttle system is designed to allow parallel delivery of siRNA reagents into difficult-to-transfect cell lines.
Additional terms of the agreement were not disclosed.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.